Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer
Clinical trial NCT02732327 · TERMINATED
Trial details
- NCT number
- NCT02732327
- Sponsor
- Forest Laboratories
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-17
- Primary completion
- 2016-06-27
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.